Table 1 Baseline characteristics of AVF patency and dysfunction group.
From: Risk factors for arteriovenous fistula dysfunction in hemodialysis patients: a retrospective study
Characteristics | Overall (n = 233) | Patency (n = 191) | Dysfunction (n = 42) | t/\({\chi }^{2}\) | P |
|---|---|---|---|---|---|
Sex | |||||
Male | 146 | 122 (63.9) | 24 (57.1) | 0.67 | 0.41 |
Female | 87 | 69 (36.1) | 18 (42.9) | ||
Age (year) | 56.11 ± 12.14 | 55.82 ± 12.10 | 57.43 ± 12.41 | − 0.78 | 0.44 |
Height (m) | 1.64 ± 0.07 | 1.64 ± 0.07 | 1.63 ± 0.06 | 0.17 | 0.87 |
Weight (kg) | 64.61 ± 11.83 | 63.79 ± 11.61 | 68.97 ± 12.23 | − 2.30 | 0.02 |
SBP (mmHg) | 84.96 ± 11.95 | 86.10 ± 11.00 | 79.71 ± 14.66 | 3.16 | < 0.01 |
DBP (mmHg) | 157.32 ± 25.13 | 158.11 ± 24.20 | 153.66 ± 29.14 | 1.03 | 0.30 |
Smoking | 29 | 26 (13.6) | 3 (7.1) | 1.32 | 0.25 |
Comorbidities | |||||
Hypertension | 198 | 164 (85.9) | 34 (81.0) | 0.65 | 0.42 |
Diabetes mellitus | 84 | 71 (37.2) | 13 (31.0) | 0.58 | 0.45 |
Coronary artery disease | 104 | 84 (44.0) | 20 (47.6) | 0.19 | 0.67 |
Peripheral vascular disease | 25 | 19 (9.9) | 6 (14.3) | 0.68 | 0.41 |
Heart failure | 63 | 51 (26.7) | 12 (28.6) | 0.06 | 0.81 |
Cause of CKD | 1.59 | 0.66 | |||
Glomerulonephritis | 109 | 90 (47.1) | 19 (45.2) | ||
Others | 114 | 93 (48.7) | 21 (50.0) | ||
Unkown | 8 | 7 (3.7) | 1 (2.4) | ||
Medication | |||||
Antiplatelet therapy | 43 | 31 (16.2) | 12 (28.6) | 3.48 | 0.06 |
Beraprost | 28 | 22 (11.5) | 6 (14.3) | 0.25 | 0.62 |
Statins | 61 | 49 (25.7) | 12 (28.6) | 0.15 | 0.70 |
